Table 1.
Discriminative performance on the final day of training (baseline) and during reactivation in each drug group in Experiments 1a and 1ba
| Infusion/drug | Baseline |
Memory reactivation |
||
|---|---|---|---|---|
| CS+ | CS− | CS+ | CS− | |
| PBS/saline | 0.75 (0.03) | 0.53 (0.05) | 0.79 (0.04) | 0.56 (0.06) |
| PBS/MK-801 | 0.75 (0.03) | 0.59 (0.05) | 0.66 (0.08) | 0.45 (0.12) |
| MB/saline | 0.77 (0.03) | 0.46 (0.05) | 0.81 (0.04) | 0.54 (0.07) |
| MB/MK-801 | 0.72 (0.04) | 0.53 (0.07) | 0.73 (0.07) | 0.53 (0.09) |
| Sulpiride/saline | 0.74 (0.04) | 0.58 (0.05) | 0.71 (0.08) | 0.45 (0.10) |
| Sulpiride/MK-801 | 0.77 (0.04) | 0.52 (0.07) | 0.77 (0.10) | 0.41 (0.13) |
| PBS | 0.76 (0.03) | 0.53 (0.05) | 0.76 (0.05) | 0.34 (0.09) |
| MK-801 | 0.79 (0.02) | 0.55 (0.06) | 0.71 (0.15) | 0.54 (0.07) |
| AP5 | 0.78 (0.04) | 0.56 (0.06) | 0.78 (0.07) | 0.56 (0.10) |
aData are mean (SEM).